Back to search

United Kingdom· GB-APID-40280111000001101

Ponvory tablets treatment initiation pack

A medicinal product containing ponesimod, registered in United Kingdom by Juvise Pharmaceuticals.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedPonvory tablets treatment initiation …ATC—REGISTER NO.GB-APID-4028011100000…PACKS LISTED3CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Ponesimod
Manufacturer
Juvise Pharmaceuticals
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 3

  • gtin
    05099467002851
  • gtin
    05012674904176
  • gtin
    03760250441653

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/331111b0-8541-4c25-b239-7664d0fc3953
GET /v1/drugs/331111b0-8541-4c25-b239-7664d0fc3953?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "40280111000001101",
  "desc": "Ponvory tablets treatment initiation pack (Juvise Pharmaceuticals)",
  "form": "Not applicable",
  "vpid": "40289811000001104",
  "source": "dmd",
  "vtm_id": "1179255001",
  "strength": null,
  "substance": "Ponesimod",
  "ingredient": null,
  "supplier_code": "45108211000001100"
}

See everything about ponesimod.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.